Over 3,000 early stage breast cancer patients treated with IORT using the Xoft system

iCAD Announces More Than 3,000 Early-Stage Breast Cancer Patients Treated with Intraoperative Radiation Therapy Using the Xoft System.

“The growing adoption and utilization of Xoft IORT further validates that it is a safe and effective treatment option, offering valuable benefits to early-stage breast cancer patients who meet specific selection criteria,” said Ken Ferry, President and Chief Executive Officer of iCAD. “The treatment of more than 3,000 patients with IORT using the Xoft System is a significant milestone and highlights the continued commitment by leading clinicians to make this clinically proven treatment option available to their patients.” 

Related Article

[Read More...]
http:/http://www.icadmed.com/icad-announces-more-than-3,000-early-stage-breast-cancer-patients-treated.html#sthash.Yo0BLGHn.dpuf

Related Article

[Read More...]

[Read More...]